India Pharma Outlook Team | Tuesday, 04 August 2026
The dental implant safety framework is under consideration by the Central government as concerns grow over the quality, regulation, and long-term safety of dental implants used across India.
The proposed initiative aims to establish comprehensive standards for dental implants, implant biomaterials, artificial teeth, and related implant systems, ensuring greater patient safety and stronger regulatory oversight.
The move comes after Rajya Sabha MP Ajeet Madhavrao Gopchade highlighted the lack of a uniform regulatory mechanism governing the manufacture, sale, and clinical use of dental implants in India.
Acting on these concerns, the Cabinet Secretariat has written to the Department of Health Research (DHR), asking it to examine the issue and take necessary action.
Dental implants are no longer limited to replacing missing teeth. They are increasingly used in oral cancer rehabilitation, facial reconstruction, and other advanced medical procedures. Because these devices remain inside the human body for years, they are considered long-term implantable medical devices rather than ordinary dental consumables.
According to Gopchade, the absence of a comprehensive regulatory framework could expose patients to significant health risks. He pointed out that poor-quality implant materials, inadequate sterilization, weak biomechanical strength, incompatibility between implant components, or manufacturing defects may lead to severe complications.
Given the increasing adoption of dental implants in both routine and complex medical treatments, the MP stressed that patient safety standards must evolve alongside technological advancements.
Also Read: Building Resilient QMS in Global Pharma Manufacturing
The proposal also highlights several challenges affecting India's dental implant market. Among the biggest concerns are the availability of non-standardized and low-quality implant systems, unverified imported implant materials, and misleading marketing practices.
The note submitted to the Cabinet Secretariat mentions that some manufacturers advertise "lifetime guarantee" claims without adequate scientific validation. It also points to the lack of uniform standards governing implant biomaterials and the absence of reliable mechanisms to trace implants after they are used in patients.
Experts believe that without consistent quality benchmarks and post-implant surveillance, identifying defective implants or tracking patient outcomes becomes significantly more difficult.
To address these issues, Gopchade has urged the government to constitute an expert committee to examine the feasibility of creating a National Dental Implant Safety and Regulatory Framework for India.
He noted that several developed countries, including the United States, the United Kingdom, and Australia, already enforce stringent regulations for implantable dental devices. These systems typically require extensive product testing, strict manufacturing standards, implant traceability, and certification requirements for practitioners performing implant procedures.
A similar framework in India could strengthen patient safety, improve quality assurance, and increase accountability across the dental implant ecosystem.
